Popular Stories

How Good Is Medical Properties Trust, Inc. (NYSE:MPW), When It Comes To ROE?

NYSE:MPW).” data-reactid=”29″>One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will work through how we can use Return On Equity (ROE) to better understand a business. By way of learning-by-doing, we’ll look at ROE to gain a better understanding of Medical Properties Trust, Inc. (NYSE:MPW).

Return on Equity or ROE is a test of how effectively a company is growing its value and managing investors’ money. Put another way, it reveals the company’s success at turning shareholder investments into profits.

View our latest analysis for Medical Properties Trust ” data-reactid=”36″>View our latest analysis for Medical Properties Trust

How To Calculate Return On Equity?

Return on Equity = Net Profit (from continuing operations) ÷ Shareholders’ Equity

So, based on the above formula, the ROE for Medical Properties Trust is:

5.8% = US$411m ÷ US$7.1b (Based on the trailing twelve months to June 2020).

The ‘return’ is the yearly profit. One way to conceptualize this is that for each $1 of shareholders’ capital it has, the company made $0.06 in profit.

Does Medical Properties Trust Have A Good ROE?

Arguably the easiest way to assess company’s ROE is to compare it with the average in its industry. Importantly, this is far from a perfect measure, because companies differ significantly within the same industry classification. You can see in the graphic below that Medical Properties Trust has an ROE that is fairly close to the average for the REITs industry (5.4%).

Our risks dashboardshould have the 4 risks we have identified for Medical Properties Trust.” data-reactid=”57″>That’s neither particularly good, nor bad. While at least the ROE is not lower than the industry, its still worth checking what role the company’s debt plays as high debt levels relative to equity may also make the ROE appear high. If so, this increases its exposure to financial risk. Our risks dashboardshould have the 4 risks we have identified for Medical Properties Trust.

How Does Debt Impact Return On Equity?

Virtually all companies need money to invest in the business, to grow profits. That cash can come from issuing shares, retained earnings, or debt. In the first and second cases, the ROE will reflect this use of cash for investment in the business. In the latter case, the debt required for growth will boost returns, but will not impact the shareholders’ equity. Thus the use of debt can improve ROE, albeit along with extra risk in the case of stormy weather, metaphorically speaking.

Medical Properties Trust’s Debt And Its 5.8% ROE

Medical Properties Trust clearly uses a high amount of debt to boost returns, as it has a debt to equity ratio of 1.09. With a fairly low ROE, and significant use of debt, it’s hard to get excited about this business at the moment. Debt does bring extra risk, so it’s only really worthwhile when a company generates some decent returns from it.

Summary

Return on equity is one way we can compare its business quality of different companies. In our books, the highest quality companies have high return on equity, despite low debt. All else being equal, a higher ROE is better.

visualization of analyst forecasts for the company.” data-reactid=”68″>Having said that, while ROE is a useful indicator of business quality, you’ll have to look at a whole range of factors to determine the right price to buy a stock. The rate at which profits are likely to grow, relative to the expectations of profit growth reflected in the current price, must be considered, too. So you might want to check this FREE visualization of analyst forecasts for the company.

free list of interesting companies with high ROE and low debt.” data-reactid=”69″>But note: Medical Properties Trust may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.

Get in touch with us directly. Alternatively, email [email protected].” data-reactid=”70″>This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected].

View Article Origin Here

Related Articles

Back to top button